Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Poly Medicure Company

POLYMED.NS
INE205C01021

Price

2,343.55
Today +/-
+0.29
Today %
+1.16 %
P

Poly Medicure stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Poly Medicure stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Poly Medicure stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Poly Medicure stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Poly Medicure's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Poly Medicure Stock Price History

DatePoly Medicure Price
10/8/20242,343.55 undefined
10/7/20242,316.50 undefined
10/4/20242,349.00 undefined
10/3/20242,310.00 undefined
10/1/20242,354.00 undefined
9/30/20242,314.75 undefined
9/27/20242,275.00 undefined
9/26/20242,324.65 undefined
9/25/20242,317.00 undefined
9/24/20242,376.20 undefined
9/23/20242,359.15 undefined
9/20/20242,341.60 undefined
9/19/20242,465.30 undefined
9/18/20242,502.85 undefined
9/17/20242,426.35 undefined
9/16/20242,449.35 undefined
9/13/20242,558.80 undefined
9/12/20242,530.00 undefined
9/11/20242,540.00 undefined
9/10/20242,547.00 undefined

Poly Medicure Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Poly Medicure, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Poly Medicure from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Poly Medicure’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Poly Medicure. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Poly Medicure’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Poly Medicure’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Poly Medicure’s growth potential.

Poly Medicure Revenue, EBIT and net profit per share

DatePoly Medicure RevenuePoly Medicure EBITPoly Medicure Net Income
2027e25.46 B undefined6.26 B undefined5.77 B undefined
2026e21.18 B undefined5.28 B undefined4.68 B undefined
2025e17.31 B undefined4.09 B undefined3.62 B undefined
202413.76 B undefined2.95 B undefined2.58 B undefined
202311.15 B undefined2.09 B undefined1.79 B undefined
20229.23 B undefined1.59 B undefined1.47 B undefined
20217.86 B undefined1.67 B undefined1.36 B undefined
20206.87 B undefined1.24 B undefined958.8 M undefined
20196.11 B undefined923.1 M undefined654 M undefined
20185.22 B undefined912 M undefined705.9 M undefined
20174.62 B undefined680 M undefined551.3 M undefined
20164.12 B undefined647.5 M undefined482.7 M undefined
20153.9 B undefined653.5 M undefined623.2 M undefined
20143.22 B undefined645.3 M undefined450.9 M undefined
20132.6 B undefined548.1 M undefined242.3 M undefined
20122.17 B undefined1.21 B undefined194.7 M undefined
20111.73 B undefined288.2 M undefined216.7 M undefined
20101.37 B undefined245.8 M undefined158 M undefined
20091.12 B undefined202.4 M undefined59.6 M undefined
2008883.8 M undefined57.5 M undefined79.2 M undefined

Poly Medicure Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
0.881.121.371.732.172.63.223.94.124.625.226.116.877.869.2311.1513.7617.3121.1825.46
-27.0722.1926.1125.5119.6824.0721.145.6112.0312.9517.1012.5114.4417.3720.8223.3725.8322.3420.19
41.4547.7748.8749.1087.8365.1965.2761.7562.6954.8956.4455.4558.4357.2253.0754.3356.07---
0.370.540.670.851.911.692.12.412.582.542.943.394.024.54.96.067.71000
0.060.20.250.291.210.550.650.650.650.680.910.921.241.671.592.092.954.095.286.26
6.4618.0017.8716.6655.5321.1020.0216.7315.7014.7217.4815.1117.9721.2217.2518.7021.4123.6124.9324.59
0.080.060.160.220.190.240.450.620.480.550.710.650.961.361.471.792.583.624.685.77
--25.32167.8036.71-10.1924.7485.9538.44-22.6314.3227.95-7.2346.4841.757.8822.3244.0840.2429.3023.24
--------------------
--------------------
92.288.188.188.188.188.288.288.288.288.288.288.288.289.29696.0296.02000
--------------------
Details

Keystats

ⓘ

Revenue and Growth

The Poly Medicure Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Poly Medicure is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
20082009201020112012201320142015201620172018201920202021202220232024
                                 
0.010.010.010.010.010.010.140.20.230.230.310.550.413.743.523.012.92
0.020.180.220.270.340.430.460.630.830.961.131.281.271.572.072.42.74
14132557411394178181181218375322340446524477.58482.58
0.140.140.220.250.30.350.420.580.460.620.730.841.121.271.682.092.21
38466850545511111631132636394492.6257.48
0.340.410.570.650.810.941.211.61.712.052.553.023.187.067.848.078.42
0.590.640.650.730.850.931.331.651.782.062.582.73.323.914.776.628.89
3113192024423440513910310812913913685.51281.54
000807241651828814513190204127318415.99325.63
002547537196105176205217236234228221215.48249.94
33333000000286286286286285.81285.81
45479156307163756210332048820375.46138.17
0.630.660.70.891.011.21.662.052.162.523.13.524.55.185.937.710.17
0.971.071.271.531.822.142.863.643.874.575.656.547.6712.2413.7715.7718.59
                                 
5555110110110110220221221441441441441479480479.72479.86
0.010.0100000.010.010.010000.013.913.913.923.93
0.350.40.480.660.811.231.722.082.272.933.323.865.226.437.9710.26
013104207685295137455139.9631.13
00000000000000000
0.420.480.60.780.941.121.461.962.312.723.383.814.359.6610.8812.4214.7
9100161199234297393309419436555664645890923.15955.98
000165683102114139154153182201254.061.25
6816423912112719130326414075113134227165294454.15845.42
00.020.050.160.160.130.10.210.340.320.320.460.570.3901.071.51
000125118111182175179208215239357334882232.85200.68
0.160.180.290.570.610.680.891.131.071.141.231.541.971.712.272.933.51
0.350.360.330.120.180.240.390.40.310.480.790.911.140.650.390.190.03
31414732546380103119148157187145130161154.35244.83
50225364041477091918970858079.9497.18
0.390.40.380.180.270.350.510.550.50.721.041.191.350.870.630.420.37
0.550.590.670.750.881.021.41.681.561.852.262.733.332.582.893.363.89
0.971.071.271.531.822.142.863.643.874.575.656.547.6712.2413.7715.7718.59
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Poly Medicure provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Poly Medicure's financial health and stability.

Assets

Poly Medicure's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Poly Medicure must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Poly Medicure after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Poly Medicure's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2008200920102011201220132014201520162017201820192020202120222023
0.080.070.180.230.290.330.530.650.650.750.960.991.241.81.952.37
57677894117129140187210237292372405475539571
0000000000000000
-73-43-81-135-137-128-200-448-278-418-604-364-480-1,058-1,108-1,078
34454031625618824149-410669144-30-14839
3747414268597982816999122100854184
10727455770177233138182231277359446474578
0.10.140.210.220.330.390.660.630.630.560.751.061.311.191.231.91
-125-110-120-238-269-308-585-543-326-586-824-780-1,060-951-1,555-2,392
-133-73-119-236-264-306-584-593-313-556-880-1,007-1,094-4,355-853-1,790
-73711420-491229-55-227-34-3,404702602
0000000000000000
71-161479421718412639199309282319-675-74195
0.01000000000000400
0.04-0.06-0.090.01-0.06-0.080.05-0.06-0.31-00.16-0.05-0.213.17-0.35-0.13
-32.00-32.00-90.00-46.00-74.00-64.00-79.00-82.00-81.00-69.00-99.00-122.00-100.00-154.00-41.00-84.00
-13-13-13-27-33-33-51-103-265-132-53-211-4240-239-239
103-601130-191012665128-6
-27.125.891.9-13.860.980.176.289.5305.8-25.4-75.3284.8244.9236-321.1-484.49
0000000000000000

Poly Medicure stock margins

The Poly Medicure margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Poly Medicure. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Poly Medicure.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Poly Medicure's sales revenue. A higher gross margin percentage indicates that the Poly Medicure retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Poly Medicure's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Poly Medicure's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Poly Medicure's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Poly Medicure. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Poly Medicure's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Poly Medicure Margin History

Poly Medicure Gross marginPoly Medicure Profit marginPoly Medicure EBIT marginPoly Medicure Profit margin
2027e56.08 %24.59 %22.67 %
2026e56.08 %24.93 %22.11 %
2025e56.08 %23.61 %20.92 %
202456.08 %21.42 %18.77 %
202354.33 %18.7 %16.08 %
202253.07 %17.25 %15.87 %
202157.22 %21.23 %17.28 %
202058.44 %17.98 %13.95 %
201955.45 %15.11 %10.71 %
201856.44 %17.48 %13.53 %
201754.89 %14.72 %11.94 %
201662.69 %15.71 %11.71 %
201561.74 %16.74 %15.97 %
201465.28 %20.02 %13.99 %
201365.18 %21.1 %9.33 %
201287.86 %55.53 %8.97 %
201149.13 %16.66 %12.53 %
201048.86 %17.92 %11.52 %
200947.79 %18.04 %5.31 %
200841.49 %6.51 %8.96 %

Poly Medicure Stock Sales Revenue, EBIT, Earnings per Share

The Poly Medicure earnings per share therefore indicates how much revenue Poly Medicure has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Poly Medicure earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Poly Medicure's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Poly Medicure’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Poly Medicure's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Poly Medicure Revenue, EBIT and net profit per share

DatePoly Medicure Sales per SharePoly Medicure EBIT per sharePoly Medicure Earnings per Share
2027e251.32 undefined0 undefined56.97 undefined
2026e209.09 undefined0 undefined46.23 undefined
2025e170.91 undefined0 undefined35.75 undefined
2024143.28 undefined30.68 undefined26.9 undefined
2023116.14 undefined21.72 undefined18.67 undefined
202296.15 undefined16.59 undefined15.26 undefined
202188.17 undefined18.72 undefined15.23 undefined
202077.92 undefined14.01 undefined10.87 undefined
201969.26 undefined10.47 undefined7.41 undefined
201859.15 undefined10.34 undefined8 undefined
201752.37 undefined7.71 undefined6.25 undefined
201646.74 undefined7.34 undefined5.47 undefined
201544.26 undefined7.41 undefined7.07 undefined
201436.54 undefined7.32 undefined5.11 undefined
201329.45 undefined6.21 undefined2.75 undefined
201224.63 undefined13.68 undefined2.21 undefined
201119.63 undefined3.27 undefined2.46 undefined
201015.57 undefined2.79 undefined1.79 undefined
200912.74 undefined2.3 undefined0.68 undefined
20089.59 undefined0.62 undefined0.86 undefined

Poly Medicure business model

Poly Medicure is one of the most popular companies on Eulerpool.com.

Poly Medicure Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Poly Medicure historical P/E ratio, EBIT multiple, and P/S ratio

Poly Medicure shares outstanding

The number of shares was Poly Medicure in 2023 — This indicates how many shares 96.021 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Poly Medicure earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Poly Medicure's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Poly Medicure’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Poly Medicure's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Poly Medicure stock splits

In Poly Medicure's history, there have been no stock splits.

Poly Medicure dividend history and estimates

In 2023, Poly Medicure paid a dividend amounting to 3 INR. Dividend means that Poly Medicure distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Poly Medicure provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Poly Medicure’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Poly Medicure's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Poly Medicure Dividend History

DatePoly Medicure Dividend
20233 undefined
20222.5 undefined
20212.5 undefined
20202 undefined
20192 undefined
20182 undefined
20171 undefined
20162 undefined
20151.25 undefined
20141 undefined
20130.5 undefined
20120.38 undefined

Poly Medicure dividend payout ratio

In 2023, Poly Medicure had a payout ratio of 17.06%. The payout ratio indicates the percentage of the company's profits that Poly Medicure distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Poly Medicure represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Poly Medicure could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Poly Medicure's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Poly Medicure Payout Ratio History

DatePoly Medicure Payout ratio
2027e16.69 %
2026e16.79 %
2025e16.68 %
202416.61 %
202317.06 %
202216.37 %
202116.4 %
202018.42 %
201926.99 %
201825 %
201716 %
201636.56 %
201517.68 %
201419.57 %
201318.18 %
201216.97 %
201117.06 %
201017.06 %
200917.06 %
200817.06 %
Unfortunately, there are currently no price targets and forecasts available for Poly Medicure.

Poly Medicure latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20237.34 6.77  (-7.82 %)2024 Q3
9/30/20235.71 6.47  (13.27 %)2024 Q2
3/31/20235.92 6.13  (3.62 %)2023 Q4
12/31/20225.1 5.21  (2.16 %)2023 Q3
12/31/20204.08 3.99  (-2.21 %)2021 Q3
1

Eulerpool ESG Scorecard© for the Poly Medicure stock

Eulerpool World ESG Rating (EESG©)

41/ 100

🌱 Environment

20

👫 Social

47

🏛️ Governance

56

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety❌
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Poly Medicure shareholders

%
Name
Stocks
Change
Date
9.64188 % Baid (Rishi)9,766,356012/31/2023
8.21609 % Zetta Matrix Consulting L.L.P.8,322,160012/31/2023
7.80684 % Baid (Himanshu)7,907,624012/31/2023
4.06473 % Lighthouse Partners4,117,208012/31/2023
3.79027 % Baid (Himanshu) HUF3,839,200012/31/2023
3.49601 % VCB Trading Pvt. Ltd.3,541,144012/31/2023
3.30928 % Jai Polypan Pvt. Ltd.3,352,000012/31/2023
3.02337 % Baid (Mukulika)3,062,400012/31/2023
2.89785 % UTI Asset Management Co. Ltd.2,935,261-118,1553/31/2024
2.74457 % Baid (Rishi) HUF2,780,000012/31/2023
1
2
3
4
5
...
7

Poly Medicure Executives and Management Board

Shri. Himanshu Baid55
Poly Medicure Managing Director, Executive Director
Compensation 130.06 M
Shri. Rishi Baid51
Poly Medicure Joint Managing Director, Executive Director (since 2014)
Compensation 124.73 M
Mr. Devendra Mehta86
Poly Medicure Non-Executive Independent Chairman of the Board
Compensation 1.6 M
Shri. Amit Khosla48
Poly Medicure Non-Executive Independent Director
Compensation 1.58 M
Dr. Shailendra Mehta64
Poly Medicure Non-Executive Independent Director
Compensation 1.55 M
1
2
3

Most common questions regarding Poly Medicure

What is the P/E ratio of Poly Medicure 2024?

The Poly Medicure P/E ratio is 87.13.

What is the P/S ratio of Poly Medicure 2024?

The Poly Medicure P/S ratio is 16.36.

What is the Quality Investing of Poly Medicure?

The Quality Investing for Poly Medicure is 10/10.

What is the revenue of Poly Medicure 2024?

The Poly Medicure revenue is 13.76 B INR.

How high is the profit of Poly Medicure 2024?

The Poly Medicure profit is 2.58 B INR.

What is the business model of Poly Medicure

No history available for Poly Medicure.

What is the Poly Medicure dividend?

Poly Medicure pays a dividend of 2.5 INR distributed over payouts per year.

How often does Poly Medicure pay dividends?

The dividend cannot currently be calculated for Poly Medicure or the company does not pay out a dividend.

What is the Poly Medicure ISIN?

The ISIN of Poly Medicure is INE205C01021.

What is the Poly Medicure ticker?

The ticker of Poly Medicure is POLYMED.NS.

How much dividend does Poly Medicure pay?

Over the past 12 months, Poly Medicure paid a dividend of 3 INR . This corresponds to a dividend yield of about 0.13 %. For the coming 12 months, Poly Medicure is expected to pay a dividend of 3 INR.

What is the dividend yield of Poly Medicure?

The current dividend yield of Poly Medicure is 0.13 %.

When does Poly Medicure pay dividends?

Poly Medicure pays a quarterly dividend. This is distributed in the months of March, October, October, October.

How secure is the dividend of Poly Medicure?

Poly Medicure paid dividends every year for the past 3 years.

What is the dividend of Poly Medicure?

For the upcoming 12 months, dividends amounting to 3 INR are expected. This corresponds to a dividend yield of 0.13 %.

In which sector is Poly Medicure located?

Poly Medicure is assigned to the 'Health' sector.

Wann musste ich die Aktien von Poly Medicure kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Poly Medicure from 10/28/2023 amounting to 3 INR, you needed to have the stock in your portfolio before the ex-date on 9/21/2023.

When did Poly Medicure pay the last dividend?

The last dividend was paid out on 10/28/2023.

What was the dividend of Poly Medicure in the year 2023?

In the year 2023, Poly Medicure distributed 2.5 INR as dividends.

In which currency does Poly Medicure pay out the dividend?

The dividends of Poly Medicure are distributed in INR.

All fundamentals about Poly Medicure

Our stock analysis for Poly Medicure Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Poly Medicure Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.